Onset of orolingual angioedema after treatment of acute brain ischemia with alteplase depends on the site of brain ischemia: A meta-analysis

North American Journal of Medical Sciences

Volumn 5, Issue 10, 2013, Pages 589-593

  Yayan, Josef ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Acute ischemic stroke; Angiotensin converting enzyme inhibitors; Ischemic stroke; Life threatening; Orolingual angioedema; Recombinant tissue plasminogen activator; Tongue swelling

Indexed keywords

ADRENALIN; ALTEPLASE; ANGIOTENSIN II ANTAGONIST; ANTIHISTAMINIC AGENT; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANGIONEUROTIC EDEMA; ARTICLE; BRAIN ISCHEMIA; BRAIN REGION; DISEASE ASSOCIATION; HEART VENTRICLE TACHYCARDIA; HUMAN; META ANALYSIS; OROLINGUAL ANGIOEDEMA; TRACHEOTOMY;

EID: 84886992266     PISSN: 22501541     EISSN: 19472714     Source Type: Journal    
DOI: 10.4103/1947-2714.120794     Document Type: Article

References (30)

1. Soler EP, Ruiz VC. Epidemiology and risk factors of cerebral ischemia and ischemic heart diseases: Similarities and differences. Curr Cardiol Rev 2010;6:138-49.
2. Sussman BJ, Fitch TS. Thrombolysis with fibrinolysin in cerebral arterial occlusion. J Am Med Assoc 1958;167:1705-9.
3. Meyer JS, Gilroy J, Barnhart MI, Johnson JF. Therapeutic thrombolysis in cerebral thromboembolism. Double-blind evaluation of intravenous plasmin therapy in carotid and middle cerebral arterial occlusion. Neurology 1963;13:927-37.
4. del Zoppo GJ, Poeck K, Pessin MS, Wolpert SM, Furlan AJ, Ferbert A, et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 1992;32:78-86.
5. Brott TG, Haley EC Jr, Levy DE, Barsan W, Broderick J, Sheppard GL, et al. Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke 1992;23:632-40.
6. Haley EC Jr, Levy DE, Brott TG, Sheppard GL, Wong MC, Kongable GL, et al. Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset. Stroke 1992;23:641-5.
7. Marler JR, Tilley BC, Lu M, Brott TG, Lyden PC, Grotta JC, et al. Early stroke treatment associated with better outcome: The NINDS rt-PA stroke study. Neurology 2000;55:1649-55.
8. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333:1581-7.
9. Wahlgren N, Ahmed N, Dávalos A, Ford GA, Grond M, Hacke W, et al. Thrombolysis with alteplase for acute ischaemic stroke in the safe implementation of thrombolysis in stroke-monitoring study (SITS-MOST): An observational study. Lancet 2007;369:275-82.
10. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian acute stroke study investigators. Lancet 1998;352:1245-51.
11. Hill MD, Barber PA, Takahashi J, Demchuk AM, Feasby TE, Buchan AM. Anaphylactoid reactions and angioedema during alteplase treatment of acute ischemic stroke. CMAJ 2000;162:1281-4.
12. Ottomeyer C, Sick C, Hennerici MG, Szabo K. Orolingual angioedema under systemic thrombolysis with rt-PA: An underestimated side effect. Nervenarzt 2009;80:459-63.
13. Hill MD, Lye T, Moss H, Barber PA, Demchuk AM, Newcommon NJ, et al. Hemi-orolingual angioedema and ACE inhibition after alteplase treatment of stroke. Neurology 2003;60:1525-7.
14. Okada Y, Shibazaki K, Sakai K, Kobayashi K, Iguchi Y, Kimura K. Orolingual angioedema as complication after rt-PA in stroke patient treated with ACE inhibitor. Rinsho Shinkeigaku 2008;48:278-80.
15. Fugate JE, Kalimullah EA, Wijdicks EF. Angioedema after tPA: What neurointensivists should know. Neurocrit Care 2012;16:440-3.
16. Yayan J. Lingual angioedema with macroglossia during the treatment of acute ischemic stroke with alteplase. Int J Gen Med 2012;5:183-6.
17. Rafii MS, Koenig M, Ziai WC. Orolingual angioedema associated with ACE inhibitor use after rtPA treatment of acute stroke. Neurology 2005;65:1906.
18. Papamitsakis NI, Kuyl J, Lutsep HL, Clark WM. Benign angioedema after thrombolysis for acute stroke. J Stroke Cerebrovasc Dis 2000;9:79-81.
19. Maertins M, Wold R, Swider M. Angioedema after administration of tPA for ischemic stroke: Case report. Air Med J 2011;30:276-8.
20. Khurana D, Sharma M, Prabhakar S. Hemi orolingual angioedema. Ann Indian Acad Neurol 2008;11:199.
21. Ekmekçi P, Bengisun ZK, Kazbek BK, Akmansu H, Beriat GK, Süer AH. Oropharyngeal angioneurotic edema due to recombinant tissue plasminogen activator following massive pulmonary thromboembolism. Int Immunopharmacol 2011;11:1384-5.
22. Laubinger R, Guthke K, Erdmann U, Klein U. Angioneurotic orolingual edema associated with the use of rt-PA following a stroke. Anaesthesist 2007;56:1024-7.
23. Krmpotic KR, Fernandes CM. Anaphylactoid reaction to recombinant tissue plasminogen activator. Eur J Emerg Med 2007;14:60-1.
24. Engelter ST, Fluri F, Buitrago-Téllez C, Marsch S, Steck AJ, Rüegg S, et al. Life-threatening orolingual angioedema during thrombolysis in acute ischemic stroke. J Neurol 2005;252:1167-70.
25. Rudolf J, Grond M, Schmülling S, Neveling M, Heiss W. Orolingual angioneurotic edema following therapy of acute ischemic stroke with alteplase. Neurology 2000;55:599-600.
26. Jahnke HK. An 89-year-old woman with angioedema during t-PA infusion for acute ischemic stroke. J Emerg Nurs 2003;29:142-4.
27. Pancioli A, Brott T, Donaldson V, Miller R. Asymmetric angioneurotic edema associated with thrombolysis for acute stroke. Ann Emerg Med 1997;30:227-9.
28. Tan CH, Tang SC, Lin RJ, Jeng JS. Neurological picture. Orolingual angio-oedema after alteplase therapy in a stroke patient concurrently using angiotensin II receptor blocker. J Neurol Neurosurg Psychiatry 2010;81:1079.
29. Molinaro G, Gervais N, Adam A. Biochemical basis of angioedema associated with recombinant tissue plasminogen activator treatment: An in vitro experimental approach. Stroke 2002;33:1712-6.
30. Kaplan AP, Joseph K, Silverberg M. Pathways for bradykinin formation and inflammatory disease. J Allergy Clin Immunol 2002;109:195-209.